TopoTarget A/S Release: Positive Subtype Data From the BELIEF Trial Presented at the 12th International Conference on Malignant Lymphoma
6/17/2013 8:57:35 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Topotarget announces that positive subtype data on angioimmunoblastic T-cell lymphoma (AITL) from the BELIEF trial with belinostat in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL) will be presented at the 12th International Conference on Malignant Lymphoma (ICML) in Lugano, Switzerland, on June 19-22, 2013.
Help employers find you! Check out all the jobs and post your resume.